Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This study is designed to assess the pharmacokinetics and safety of an infusion of a single dose of recombinant plasma gelsolin (rhu-pGelsolin) when given to patients admitted to the Intensive Care Unit with documented low levels of natural gelsolin. It is believed that this drug will raise the gelsolin levels in these patients and decrease the probability that they will develop complications from their underlying disease such as organ system failure or death.
Epistemonikos ID: 7e7878f3ea4b035d2e3a93bbc22389616d0ae5eb
First added on: May 05, 2024